Omics Revolution: AI and Atlas Drive Future of Medicine at TICSSO-4

BEIJING, China – April 17, 2026 – The future of medicine was on full display in Beijing as over 5,000 of the world’s leading scientists, entrepreneurs, and investors gathered for the 4th International Conference on Single-Cell and Spatial Omics (TICSSO-4). Held from March 28 to 30, the landmark event, themed "Atlas • AI • Acceleration," showcased the transformative power of technologies that are providing an unprecedented view into the very building blocks of life and disease.

The conference served as a powerful testament to the momentum of single-cell and spatial omics, fields that are rapidly moving from niche research tools to the forefront of biomedical discovery and clinical application. The sheer scale of participation, both in-person and via an international online forum, highlighted a global consensus: understanding the complexity of individual cells in their native environment is the key to unlocking the next generation of diagnostics and therapies.

The Cellular Frontier: Decoding the Omics Revolution

For decades, biological research relied on methods that analyzed tissues by grinding up millions of cells, yielding an averaged, and often misleading, result. The revolution discussed at TICSSO-4 is a shift from this blurry, bulk perspective to one of stunning clarity.

Single-cell omics allows scientists to isolate and analyze the molecular makeup—including the DNA, RNA, and proteins—of one cell at a time. This reveals the vast cellular heterogeneity hidden within seemingly uniform tissues. It is in these subtle differences between cells that scientists can find the origins of cancer, the specific neurons affected by a neurodegenerative disorder, or the rare immune cells that successfully fight off an infection. It’s the difference between hearing the roar of a crowd and listening to the individual conversations that comprise it.

Complementing this is spatial omics, a suite of technologies that adds a crucial layer of context: location. It answers not just what molecules are in a cell, but where that cell is situated within a tissue and who its neighbors are. By creating detailed molecular maps, spatial omics reveals the intricate cellular communities and communication networks that govern tissue function in health and disease. This is particularly vital for understanding the tumor microenvironment, where the interplay between cancer cells and surrounding immune and stromal cells can determine whether a tumor grows or a therapy succeeds.

Together, these technologies are creating multi-dimensional views of biology that were once the realm of science fiction, enabling research that is profoundly impacting our understanding of everything from embryonic development to the mechanisms of aging.

"Atlas, AI, Acceleration": A New Paradigm in Discovery

The conference's theme perfectly captured the field's current trajectory. "Atlas" points to the global effort, akin to the Human Genome Project, to map every cell type in the human body, such as the Human Cell Atlas. These comprehensive cellular maps serve as foundational references for understanding health and identifying the changes that lead to disease.

"AI" represents the critical role of artificial intelligence and machine learning in making sense of the colossal datasets generated by omics technologies. The complexity of single-cell and spatial data is beyond human capacity to analyze alone. AI algorithms are essential for identifying patterns, predicting cellular behavior, and integrating multiple layers of data—for instance, combining a cell's genetic code with its spatial location and protein expression—to generate powerful new insights. A keynote address by Academician Xiaoliang Xie of Peking University, titled "What Can FOODIE Do for Biology and Medicine," hinted at the development of such sophisticated new tools for extracting deep biological meaning from complex data.

Finally, "Acceleration" underscores the ultimate goal: translating these fundamental discoveries into tangible medical solutions. The nine thematic forums at TICSSO-4, covering topics from neuroscience and immunity to cancer and aging, were filled with presentations on how omics is speeding up the identification of drug targets, the design of precision therapies, and the development of novel diagnostic biomarkers.

A Global Hub for Life Science: China's Growing Influence

The journey of TICSSO itself tells a story of remarkable growth and ambition. Founded in 2022 by leading researchers Professor Xinghua Pan, Professor Fuchou Tang, and Professor Guoji Guo, the conference has rapidly expanded, moving from its inaugural event in Guangzhou to subsequent gatherings in Shenzhen, Shanghai, and now the nation’s capital, Beijing.

"From Guangzhou, to Shenzhen, to Shanghai, and now to Beijing, TICSSO has grown from a vision into a thriving community," said Professor Xinghua Pan of Macau University of Science and Technology in his opening address. He emphasized the conference's mission to build an interdisciplinary and international platform to advance the field. "It is our shared commitment to the frontiers of life sciences that has brought together this remarkable community of academia and industry."

The event's co-organization by a consortium of prestigious Chinese institutions—including Macau University of Science and Technology, Chongqing Medical University, and the Human Phenome Institute of Fudan University—signals a concerted national effort to lead in this critical area of science. The scale and success of TICSSO-4 position China not just as a participant, but as a major global hub for life science innovation, capable of convening top international talent and driving the global scientific conversation.

Bridging the Gap from Lab Bench to Patient Bedside

A defining feature of TICSSO-4 was its emphasis on the synergy between academic research and industrial application. The conference is more than a forum for scientific presentations; it is a marketplace of ideas where breakthrough discoveries meet the entrepreneurial drive to turn them into real-world products.

This commitment was highlighted by the presentation of the "Annual Technological Innovation Pioneer Award" to dozens of outstanding enterprises. These awards recognize companies at the forefront of developing the innovative reagents, high-throughput devices, and powerful software that underpin the omics revolution. By celebrating and fostering these industry partnerships, TICSSO helps accelerate the often-long journey from a discovery in a university lab to a diagnostic test or therapeutic drug available to patients.

The 64 scientific presentations delivered at the conference painted a comprehensive panorama of a field that is firing on all cylinders, from technological breakthroughs and fundamental scientific discoveries to their direct clinical translation. The energy at TICSSO-4 was palpable—a shared sense of purpose among thousands of researchers and innovators who are not just observing the future of medicine, but actively building it, one cell at a time.